Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease

@inproceedings{Sena2013DysregulationOA,
  title={Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease},
  author={Angela Aparecida Servino Sena and Irina B Grishina and Anne Thai and Larissa Goulart and Monica Macal and Anne N. Fenton and Jay Y. Li and Thomas Prindiville and S{\^o}nia Maria Oliani and Satya Dandekar and Lu{\'i}z Ricardo Goulart and Sumathi Sankaran-Walters},
  booktitle={PloS one},
  year={2013}
}
BACKGROUND Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic factors with the host immune system. Mechanisms contributing to immune dysregulation in IBD are not fully defined. Development of novel therapeutic strategies is focused on controlling aberrant immune response in IBD. Current IBD therapy utilizes a combination of immunomodulators and biologics to suppress pro-inflammatory effectors of IBD. However, the role of immunomodulatory factors… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Functional analysis of human T cell subsets defined by CD45 isoform expression.

Seminars in immunology • 1992
View 9 Excerpts
Highly Influenced

Adverse effects of biologics used for treating IBD.

Best practice & research. Clinical gastroenterology • 2010
View 2 Excerpts
Highly Influenced

Attenuation of plasma annexin A1 in human obesity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology • 2013
View 1 Excerpt

Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology • 2011
View 6 Excerpts

Similar Papers

Loading similar papers…